Eurofins Scientific SE
ERF: XPAR (FRA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€84.00 | Tbdjdb | Xzckbzfh |
Eurofins Meets Q1 Expectations, Though Core Growth Offset by Lower COVID-19 Sales; Maintain FVE
Narrow-moat Eurofins provided a first-quarter sales update that largely met our expectations, and we still expect full-year sales to decline from lower COVID-19-related contribution. We are maintaining our EUR 80 fair value estimate.